Skip to main content

Table 1 YY1 scoring as continuous variable

From: YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma

  YY1 - 0 YY1 - 1 YY1 - 2 YY1 - 3 YY1 - 4
Clinical features 4 patients 9 patients 4 patients 9 patients 15 patients
Age 16.3 ± 7.4 30.1 ± 23.9 13.0 ± 2.2 12.3 ± 8.9 19.7 ± 13.4
Gender      
Male 25.0 66.7 100.0 66.0 73.3
Chemonecrosis ≥ 90% 50.0 33.3 25.0 33.3 40.0
Metachronous metastasis (%)* 0 12.5 75.0 60.0 88.9
Mortality 25.0 22.2 50.0 66.7 53.3
Mean follow -up 50.3 ± 31.6 39.7 ± 21.0 62.0 ± 37.3 43.6 ± 23.0 48.5 ± 25.6
  1. *Data reported are from the 27 patients free of metastasis at baseline and expressed in percentage